Products
Companies
News
About
About
FAQ
Contact
Contact
Newsletter
×
Subscribe to our monthly newsletter
Subscribe
Products
Breast-SlimView
Breast-SlimView
Hera-MI
Breast-SlimView is a clinical decision support solution for 2D/3D mammography. It has learnt to detect what is normal from a database of mammograms, then, based on this normalized database, it learns to detect and highlight suspicious areas. Breast-SlimView’s algorithm automatically detects and removes all normal physiological areas (vessels, glandular tissue, fatty tissue and mammary gland) and replace them by artificial fat.
Information source:
Vendor
Last updated:
August 3, 2020
General Information
Technical Specifications
Regulatory
Market
Evidence
General Information
General
Product name
Breast-SlimView
Company
Hera-MI
Subspeciality
Breast
Modality
Mammography
Disease targeted
Breast cancer
Key-features
Images negativation, risk mapping, breast density.
Suggested use
Before: stratifying reading process (non, single, double read)
During: perception aid (prompting all abnormalities/results/heatmaps), interactive decision support (shows abnormalities/results only on demand)
After: diagnosis verification
Technical Specifications
Data characteristics
Population
Breast cancer screening population
Input
2D & 3D mammography, reports.
Input format
DICOM
Output
2D & 3D negativated mammography, density results.
Output format
DICOM
Technology
Integration
Integration in standard reading environment (PACS), Integration via AI marketplace or distribution platform, Stand-alone third party application
Deployment
Locally on dedicated hardware, Locally virtualized (virtual machine, docker)
Trigger for analysis
Automatically, right after the image acquisition, On demand, triggered by a user through e.g. a button click, image upload, etc.
Processing time
10 - 60 seconds
Regulatory
Certification
CE
Certified, Class IIa
, MDD
FDA
No or not yet
Intended Use Statements
Intended use (according to CE)
Market
Market presence
On market since
02-2020
Distribution channels
Countries present (clinical, non-research use)
Paying clinical customers (institutes)
Research/test users (institutes)
Pricing
Pricing model
Pay-per-use, Subscription
Based on
Number of users, Number of installations, Number of analyses
Evidence
Evidence
Peer reviewed papers on performance
Non-peer reviewed papers on performance
Other relevant papers